What’s the ‘why’ behind AI in clinical trials? How can AI best amplify—not replace—the human experience?
Behind every medical breakthrough—every milestone in drug development—there remains a constant. With AI at our disposal, we have the ability to realign our focus on those who matter most: the patients.
As artificial intelligence becomes increasingly popular, the goal of AI in clinical trials remains the same: to help and assist users, augmenting their ability to perform human-centric research. Gone are the days spending hours sifting through thousands of clinical records and forms. With AI, we have the power to make the lives of clinical trial sponsors, investigators, research coordinators, sites, and doctors easier, in turn making their work better for those who matter most. And that’s the true power of AI.
In this presentation—originally presented at YPrime’s annual Innovation Network Gathering—Dr. Ghayath Janoudi, Founding CEO of Loon, Inc. Biosciences, explores the bigger story and context driving AI, and how AI can best amplify the human experience in clinical trials. As Dr. Janoudi notes, AI is not a substitute for human expertise and compassion, but a powerful ally, augmenting our capabilities to enhance patient care and clinical trial outcomes going forward. Tune in below to learn where we are headed as an industry incorporating artificial intelligence in clinical trial technology.
Innovation and quality are at the core of everything we do as an industry to improve clinical trials. That’s why every year, we host the Innovation Network Gathering—a forum for brilliant minds from various backgrounds to come together to engage in thought-provoking discourse that sparks new opportunities for growth and change.
Check out our other AI resources
about trial design, data capture, operational efficiencies, and, ultimately, solving for certainty in clinical research.
